Current status of bevacizumab in advanced ovarian cancer
about
Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatmentAngiogenesis and antiangiogenic agents in cervical cancer.Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cellsInhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer.Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content.
P2860
Q28075761-B31A7A13-E5D6-4134-A2CC-2466DA9DA6F2Q34655335-D2624C98-BF93-4223-9294-A0893B3C5895Q36419610-55F6913B-CC7D-42AF-9E53-60072C4856EFQ36592509-FF4E34D2-2D9E-42D1-9D0D-2E29812CB5AFQ37196532-81DF8786-B4E3-4D02-ABB1-D89A2CAEAA3AQ37581516-B5E5E859-61C0-4143-9D54-560F1DBE123EQ38203882-F6744407-B330-4A72-990A-399FC4E507B1Q40962247-4AD42E0D-D34D-4462-A945-699F13EA6927
P2860
Current status of bevacizumab in advanced ovarian cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current status of bevacizumab in advanced ovarian cancer
@en
Current status of bevacizumab in advanced ovarian cancer.
@nl
type
label
Current status of bevacizumab in advanced ovarian cancer
@en
Current status of bevacizumab in advanced ovarian cancer.
@nl
prefLabel
Current status of bevacizumab in advanced ovarian cancer
@en
Current status of bevacizumab in advanced ovarian cancer.
@nl
P2093
P2860
P356
P1476
Current status of bevacizumab in advanced ovarian cancer
@en
P2093
Anselmo Papa
Davide Caruso
Federica Tomao
Luigi Rossi
Martina Venezia
Silverio Tomao
P2860
P304
P356
10.2147/OTT.S46301
P407
P577
2013-07-22T00:00:00Z